Home
/
Records
/
Fda Inspections
/
Misemer Pharmaceutical

FDA Inspection

•Misemer Pharmaceutical•February 23, 2026

FDA Inspection 1304158 - Misemer Pharmaceutical - February 23, 2026

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Record Details

This FDA Inspection record concerns Misemer Pharmaceutical, with an inspection on February 23, 2026, covering drugs.

Company: Misemer Pharmaceutical
Inspection Date: February 23, 2026
Product Type: Drugs

Open in Dashboard

ID · df136ee9-7364-4561-a5e3-27b2ebab7ee9

Violation Codes3

21 CFR 314.80(b)21 CFR 314.80(c)(2)21 CFR 314.81(b)(2)

Full citation text and observation details available on the Dashboard.

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

[email protected]

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA Inspection 1304158 - Misemer Pharmaceutical - February 23, 2026 | Global Key Solutions